Abstract
SUMOylation, a posttranslational modification process in which SUMO, the small ubiquitin-related modifier or small ubiquitin-like modifier, is added to the target proteins, plays an important role in regulating a variety of cellular processes including protein-protein interactions, subcellular localization, protein-DNA interactions and enzyme activity. This process adds another layer of control in eukaryote gene expression, and it regulates both transcriptional activation and repression. In the present review, we summarized the currently emerging information regarding the function of SUMOylation in ocular development and pathology.
Keywords: SUMOylation, gene expression, retina, lens, cornea, Pax-6, LEDGF, Nr2e3, Nrl, development, differentiation, signal transduction, ubiquitination, transcription, environmental stimuli, homeostasis, conjugated, proteeasome, sentrin-specific proteases, erythroleukemia, Histone deacetylase, rhodopsin, homeodomain genes, enhanceosome, mutations, neuroretina, rostral telencephalon, immunohistochemistry, neuroectoderm, pseudo-optic, autoimmunity
Current Molecular Medicine
Title: SUMOylation in Ocular Development and Pathology
Volume: 10 Issue: 9
Author(s): L. Gong and D. W.-C. Li
Affiliation:
Keywords: SUMOylation, gene expression, retina, lens, cornea, Pax-6, LEDGF, Nr2e3, Nrl, development, differentiation, signal transduction, ubiquitination, transcription, environmental stimuli, homeostasis, conjugated, proteeasome, sentrin-specific proteases, erythroleukemia, Histone deacetylase, rhodopsin, homeodomain genes, enhanceosome, mutations, neuroretina, rostral telencephalon, immunohistochemistry, neuroectoderm, pseudo-optic, autoimmunity
Abstract: SUMOylation, a posttranslational modification process in which SUMO, the small ubiquitin-related modifier or small ubiquitin-like modifier, is added to the target proteins, plays an important role in regulating a variety of cellular processes including protein-protein interactions, subcellular localization, protein-DNA interactions and enzyme activity. This process adds another layer of control in eukaryote gene expression, and it regulates both transcriptional activation and repression. In the present review, we summarized the currently emerging information regarding the function of SUMOylation in ocular development and pathology.
Export Options
About this article
Cite this article as:
Gong L. and W.-C. Li D., SUMOylation in Ocular Development and Pathology, Current Molecular Medicine 2010; 10 (9) . https://dx.doi.org/10.2174/156652410793937769
DOI https://dx.doi.org/10.2174/156652410793937769 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Minocycline in Ischemia-Reperfusion Injury: A Comprehensive Review of an Old Drug with New Implications
Recent Patents on Cardiovascular Drug Discovery Secretoneurin: A New Player in Angiogenesis and Chemotaxis Linking Nerves, Blood Vessels and the Immune System
Current Protein & Peptide Science The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Mitochondrial Proteases as Emerging Pharmacological Targets
Current Pharmaceutical Design GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Current Neuropharmacology Epigenomic-Basis of Preemptive Medicine for Neurodevelopmental Disorders
Current Genomics Cytochrome P450 in Neurological Disease
Current Drug Metabolism QSAR Approaches Applied to Antidepressants Induced Neurogenesis - in vivo and in silico Applications
Mini-Reviews in Medicinal Chemistry Inwardly Rectifying Potassium Channels in the Regulation of Vascular Tone
Current Drug Targets Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology Glycosphingolipid Structure and Function in Membranes
Current Organic Chemistry Hypoxia, Lead Toxicities and Oxidative Stress: Cell Signaling, Molecular Interactions and Antioxidant (Vitamin C) Defense
Current Signal Transduction Therapy Clinical, Genetic, and Neuroimaging Features of Early Onset Alzheimer Disease: The Challenges of Diagnosis and Treatment
Current Alzheimer Research Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer
Current Pharmaceutical Design Cognitive Impairment with Vascular Impairment and Degeneration
Current Neurovascular Research Immunological Mechanisms of Neuropsychiatric Lupus
Current Immunology Reviews (Discontinued) Tetrahydrobiopterin Pathway may Provide Novel Molecular Targets for Acute and Long Term Efficacy of Mood-Regulating Drugs
Current Pharmacogenomics and Personalized Medicine Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Current Drug Abuse Reviews The Application of PET Technique for the Development and Evaluation of Novel Antipsychotics
Current Pharmaceutical Design